4.6 Article

Remodeling the ECM: Implications for Metastasis and Tumor Dormancy

期刊

CANCERS
卷 13, 期 19, 页码 -

出版社

MDPI
DOI: 10.3390/cancers13194916

关键词

ECM; cancer dormancy; metastasis

类别

资金

  1. NCI R01 [CA244780]
  2. Susan G. Komen Career Catalyst Research [CCR18547848]
  3. Tisch Cancer Institute NIH Cancer Center grant [P30-CA196521]

向作者/读者索取更多资源

While most primary tumors can be effectively treated, the challenge lies in eliminating metastases efficiently. Recent studies have shown that ECM plays a crucial role in cancer progression, regulating tumor cell metastasis and dormancy. Understanding the individual components of ECM and how they mediate tumor cell dormancy may lead to the development of new therapies targeting dormant cells and preventing metastasis outgrowth.
While most primary tumors can be effectively treated, therapeutics fail to efficiently eliminate metastases. Metastases arise from cancer cells that leave the primary tumor and seed distant sites. Recent studies have shown that cancer cells disseminate early during tumor progression and can remain dormant for years before they resume growth. In these metastatic organs, cancer cells reside in microenvironments where they interact with other cells, but also with the extracellular matrix (ECM). The ECM was long considered to be an inert, non-cellular component of tissues, providing their architecture. However, in recent years, a growing body of evidence has shown that the ECM is a key driver of cancer progression, and it can exert effects on tumor cells, regulating their metastatic fate. ECM remodeling and degradation is required for the early steps of the metastatic cascade: invasion, tumor intravasation, and extravasation. Similarly, ECM molecules have been shown to be important for metastatic outgrowth. However, the role of ECM molecules on tumor dormancy and their contribution to the dormancy-supportive niches is not well understood. In this perspective article, we will summarize the current knowledge of ECM and its role in tumor metastasis and dormancy. We will discuss how a better understanding of the individual components of the ECM niche and their roles mediating the dormant state of disseminated tumor cells (DTCs) will advance the development of new therapies to target dormant cells and prevent metastasis outgrowth.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据